NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study of Mast Cell Precursors

Completed

Conditions: Mastocytosis
Healthy Volunteer

First Posted Date: 1999-11-04

Last Posted Date: 2022-11-07

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 202

Registration Number: NCT00001756

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Role of T-Cells in Asthma

Completed

Conditions: Asthma

First Posted Date: 1999-11-04

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 250

Registration Number: NCT00001408

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies

Terminated

Conditions: Leukopheresis
Plasmapheresis

First Posted Date: 1999-11-04

Last Posted Date: 2021-11-10

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 205

Registration Number: NCT00001349

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients

Completed

Conditions: Acquired Immunodeficiency Syndrome
HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 56

Registration Number: NCT00001650

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Recruiting

Conditions: Benign Lymphoproliferative Disorder

First Posted Date: 1999-11-04

Last Posted Date: 2024-12-17

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1200

Registration Number: NCT00001350

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up

Phase 1

Completed

Conditions: Chronic Granulomatous Disease
Communicable Disease

First Posted Date: 1999-11-04

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 14

Registration Number: NCT00001476

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV

Recruiting

Conditions: Infectious Diseases
HIV
Immunodeficiencies

First Posted Date: 1999-11-04

Last Posted Date: 2024-12-17

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 2400

Registration Number: NCT00001281

Locations: 🇺🇸
Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Fungal Infection Susceptibility

Recruiting

Conditions: Cryptococcal Meningitis
Pulmonary Cryptococcosis
Cryptococcosis
Cryptococcal Infection
Cryptococcal Pneumonia

First Posted Date: 1999-11-04

Last Posted Date: 2024-12-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 800

Registration Number: NCT00001352

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Host Response to Infection and Treatment in Filarial Diseases

Recruiting

Conditions: Mansonelliasis
Filariasis
Helminthiasis
Parasitic Infection
Onchocerciasis

Interventions: Drug: Diethylcarbamazine

First Posted Date: 1999-11-04

Last Posted Date: 2024-11-19

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 500

Registration Number: NCT00001230

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Detection and Characterization of Host Defense Defects

Recruiting

Conditions: Immune Defects

First Posted Date: 1999-11-04

Last Posted Date: 2024-12-19

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 3600

Registration Number: NCT00001355

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy